|
| Theme |
Subtheme |
Study |
Findings |
|
|
| Prevalence of Delirium in Advanced Cancer Patients |
Delirium prevalence in palliative care for advanced cancer |
Mercadante et al. (2018) [41] |
- 17.5% of advanced cancer patients experienced delirium during palliative care - Delirium decreased to 10.3% after one week of intervention |
|
| Chishi et al. (2023) [10] |
- Delirium prevalence rate of 24.1% - Improvement observed after palliative intervention |
|
| Maeda et al. (2020) [39] |
- 22.1% of advanced cancer patients experienced delirium during palliative care |
|
| Prevalence of delirium in diverse palliative care settings |
De La Cruz et al. (2015) [11] |
- A 10.3% delirium prevalence rate among cancer patients admitted to an acute palliative care unit- A 30.5% delirium incidence rate in patients admitted to an acute palliative care unit |
|
| Chishi et al. (2023) [10] |
- A 62% delirium prevalence rate among patients admitted to a hospice center - Reduced to 24.1% with treatment |
|
| Mercadante et al. (2018) [41] |
- 11.5% delirium prevalence rate among advanced cancer patients in home care and hospice |
|
| Management and Treatment of Delirium in Advanced Cancer Patients |
Efficacy of pharmacological interventions in the management of delirium in advanced cancer |
Agar et al. (2017) [1] |
- Risperidone and haloperidol are more effective than placebo in reducing delirium symptoms - No significant difference between the two antipsychotics in terms of efficacy or safety |
|
| Okuyama et al. (2019) [45] |
- Current pharmacotherapy did not improve the severity of hypoactive delirium in patients with advanced cancer |
|
| Maeda et al. (2020) [39] |
- Antipsychotic medication for delirium was effective and safe in real-world palliative care settings |
|
| Efficacy of non-pharmacological approach in management of delirium in advanced cancer |
Tatematsu et al. (2011) [48] |
- Exercise therapy effective in reducing delirium in cancer patients |
|
| Mercadante et al. (2018) [41] |
- Palliative care associated with a reduction in the incidence and severity of delirium |
|
| Matsuda et al. (2020) [40] |
- Multicomponent interventions involving non-pharmacological approaches were effective- Environmental modifications reduced the severity and duration of delirium |
|
| Chishi et al. (2023) [10] |
- Addressing the physical, emotional, and spiritual needs of the patient showed positive impacts- Incorporating palliative care interventions may be effective in managing delirium |
|
| Reversibility of Delirium in Hospitalised Cancer Patients |
|
Mercadante et al. (2018) [41], Chishi et al. (2023) [10], Matsuda et al. (2021) [40], |
- Delirium in hospitalized cancer patients generally reversible- Improvements observed with palliative care interventions, antipsychotic medications, and exercise therapy |
|
| |
Matsuda et al. (2021) [40], |
- Delirium reversibility rate may vary depending on the underlying etiology- Identifying and managing underlying etiologies crucial in improving delirium outcomes |
|
| |
Okuyama et al. (2019) [45], |
- Pharmacotherapy for managing delirium symptoms may have limited efficacy in hypoactive delirium subtype |
|
| |
Agar et al. (2017) [1] |
- Risperidone and haloperidol effective in managing delirium symptoms in palliative care patients |
|
